Connection

Gary Gilkeson to Graft vs Host Disease

Back to Details
This is a "connection" page, showing publications Gary Gilkeson has written about Graft vs Host Disease.
Gary Gilkeson
Connection Strength
0.677
Graft vs Host Disease
  1. Safety and Efficacy of Mesenchymal Stromal Cells and Other Cellular Therapeutics in Rheumatic Diseases in 2022: A Review of What We Know So Far. Arthritis Rheumatol. 2022 05; 74(5):752-765.
    View in: PubMed
    Score: 0.677
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.